[1] |
VIGUIER C, ARORA S, GILMARTIN N, et al. Mastitis detection:current trends and future perspectives[J]. Trends Biotechnol, 2009, 27(8):486-493.
|
[2] |
RUEGG P L. A 100-year review:Mastitis detection, management, and prevention[J]. J Dairy Sci, 2017, 100(12):10381-10397.
|
[3] |
尹荣兰, 张乃生, 杨正涛,等. 奶牛乳腺炎防治研究进展[J]. 动物医学进展, 2007, 28(5):79-82.YIN R L, ZHANG N S, YANG Z T, et al. Progress on prevention and treatment of cow mastitis[J]. Progress in Veterinary Medicine, 2007, 28(5):79-82. (in Chinese)
|
[4] |
GUIDRY A J, O'BRIEN C N, DOUGLASS L W. A bovine mammary endothelial/epithelial cell culture model of the blood/milk barrier[J]. Can J Vet Res, 1998, 62:117-121.
|
[5] |
RYMAN V E, PACKIRISWAMY N, SORDILLO L M. Role of endothelial cells in bovine mammary gland health and disease[J]. Anim Health Res Rev, 2015, 16(2):135-149.
|
[6] |
GILBERT F B, CUNHA P, JENSEN K, et al. Differential response of bovine mammary epithelial cells to Staphylococcus aureus or Escherichia coli agonists of the innate immune system[J]. Vet Res, 2013, 44:40.
|
[7] |
BAYLES K W, WESSON C A, LIOU L E, et al. Intracellular Staphylococcus aureus escapes the endosome and induces apoptosis in epithelial cells[J]. Infect Immun, 1998, 66(1):336-342.
|
[8] |
BOCHNIARZ M, ZDZISIŃSKA B, WAWRON W, et al. Milk and serum IL-4, IL-6, IL-10, and amyloid A concentrations in cows with subclinical mastitis caused by coagulase-negative Staphylococci[J]. J Dairy Sci, 2017, 100(12):9674-9680.
|
[9] |
ALLUWAIMI A M. The cytokines of bovine mammary gland:prospects for diagnosis and therapy[J]. Res Vet Sci, 2004, 77(3):211-222.
|
[10] |
ZHAO Y Y, YAN D J, CHEN Z W. Role of AIF-1 in the regulation of inflammatory activation and diverse disease processes[J]. Cell Immunol, 2013, 284(1-2):75-83.
|
[11] |
NAGAKAWA Y, NOMOTO S, KATO Y, et al. Over-expression of AIF-1 in liver allografts and peripheral blood correlates with acute rejection after transplantation in rats[J]. Am J Transplant, 2004, 4(12):1949-1957.
|
[12] |
CHEN Z W, OSTENSON C G. BERGMAN T, et al. Isolation and structural analysis of a novel peptide daintain[J]. Eur J Endocrinol. 1994, 130(Suppl):32-36.
|
[13] |
UTANS U, ARCECI R J, YAMASHITA Y, et al. Cloning and characterization of allograft inflammatory factor-1:a novel macrophage factor identified in rat cardiac allografts with chronic rejection[J]. J Clin Invest, 1995, 95(6):2954-2962.
|
[14] |
IRIS F J, BOUGUELERET L, PRIEUR S, et al. Dense Alu clustering and a potential new member of the NF-κB family within a 90 kilobase HLA class Ⅲ segment[J]. Nat Genet, 1993, 3(2):137-145.
|
[15] |
ORSMARK C, SKOOG T, JESKANEN L, et al. Expression of allograft inflammatory factor-1 in inflammatory skin disorders[J]. Acta Derm Venereol, 2007, 87(3):223-227.
|
[16] |
ZHAO Y Y, HUANG X Y, CHEN Z W. Daintain/AIF-1(allograft inflammatory factor-1) accelerates type 1 diabetes in NOD mice[J]. Biochem Biophys Res Commun, 2012, 427(3):513-517.
|
[17] |
YANG Z F, HO D W, LAU C K, et al. Allograft inflammatory factor-1(AIF-1) is crucial for the survival and pro-inflammatory activity of macrophages[J]. Int Immunol, 2005, 17(11):1391-1397.
|
[18] |
TIAN Y, KELEMEN S E, AUTIERI M V. Inhibition of AIF-1 expression by constitutive siRNA expression reduces macrophage migration, proliferation, and signal transduction initiated by atherogenic stimuli[J]. Am J Physiol Cell Physiol, 2006, 290(4):C1083-1091.
|
[19] |
WATANO K, IWABUCHI K, FUJⅡ S, et al. Allograft inflammatory factor-1 augments production of interleukin-6, -10 and -12 by a mouse macrophage line[J]. Immunology, 2001,104(3):307-316.
|
[20] |
LIU G W, MAI H X, JIANG L L, et al. Allograft inflammatory factor-1 and its immune regulation[J]. Autoimmunity, 2007, 40(2):95-102.
|
[21] |
DEININGER M H, MEYERMANN R, SCHLUESENER H J. The allograft inflammatory factor-1 family of proteins[J]. FEBS Lett, 2002, 514(2-3):115-121.
|
[22] |
TOVEY M G, LALLEMAND C. Adjuvant activity of cytokines[J]. Methods Mol Biol, 2010, 626:287-309.
|
[23] |
ZHOU X, HE Z, HENEGAR J, et al. xpression of allograft inflammatory factor-1(AIF-1) in acute cellular rejection of cardiac allografts[J]. Cardiovasc Pathol, 2011, 20(5):177-184.
|
[24] |
SCHLUESENER H J, SEID K, MEYERMANN R. Effects of autoantigen and dexamethasone treatment on expression of endothelial-monocyte activating polypeptide Ⅱ and allograft-inflammatory factor-1 by activated macrophages and microglial cells in lesions of experimental autoimmune encephalomyelitis, neuritis and uveitis[J]. Acta Neuropathol (Berl), 1999, 97(2):119-126.
|
[25] |
EGAÑA-GORROÑO L, CHINNASAMY P, CASIMIRO I, et al. Allograft inflammatory factor-1 supports macrophage survival and efferocytosis and limits necrosis in atherosclerotic plaques[J]. Atherosclerosis, 2019, 289:184-194.
|
[26] |
LIU S, TAN W Y, CHEN Q R, et al. Daintain/AIF-1 promotes breast cancer proliferation via activation of the NF-κB/cyclin D1 pathway and facilitates tumor growth[J]. Cancer Sci, 2008, 99(5):952-957.
|
[27] |
GÜNTHER J, ESCH K, POSCHADEL N, et al. Comparative kinetics of Escherichia coli- and Staphylococcus aureus-specific activation of key Immune pathways in mammary epithelial cells demonstrates that S. aureus elicits a delayed response dominated by interleukin-6(IL-6) but not by IL-1A or tumor necrosis factor alpha[J]. Infect Immun, 2010, 79(2):695-707.
|
[28] |
YADAV A, SAINI V, ARORA S. MCP-1:chemoattractant with a role beyond immunity:a review[J]. Clin Chim Acta, 2010, 411(21-22):1570-1579.
|
[29] |
OVIEDO-BOYSO J, VALDEZ-ALARCÓN J J, CAJERO-JUÁREZ M, et al. Innate immune response of bovine mammary gland to pathogenic bacteria responsible for mastitis[J]. J Infect, 2007, 54(4):399-409.
|
[30] |
HUANG S, RUTKOWSKY J M, SNODGRASS R G, et al. Saturated fatty acids activate TLR-mediated proinflammatory signaling pathways[J]. J Lipid Res, 2012, 53(9):2002-2013.
|
[31] |
ZHOU Y N, LI X, YUAN X Y, et al. Role of allograft inflammatory factor-1 in the regulation of inflammation and oxidative stress in primary peritoneal mesothelial cells[J]. Cell Biol Int, 2019, 43(5):495-505.
|